We have been fortunate to have our new advisory board member Dr. Stanley Simiyu, who has a vast background in non-governmental organization field of work and has worked with various not for profit organization in Kenya. Dr. Simiyu has now joined Rachael K Foundation at the capacity of a medical expert and advisor to the organization.
ROW Foundation has partnered with Rachael K Foundation to grant an ongoing supply of the anti-seizure medication Roweepra® (levetiracetam USP). The medication donated by OWP Pharmaceuticals will be dispensed to beneficiaries in Kenya who live with epilepsy, which affects 30 to 50 percent of children with epilepsy. The medication donated by OWP pharmaceutical will be dispensed to beneficiaries identified by Rachael K Foundation in Kenya who live with epilepsy, which affects 30-50 percent of children with epilepsy.